High Court Won't Hear Pliva's Generic Preemption Case
By Sindhu Sundar (March 30, 2015, 12:21 PM EDT) -- The U.S. Supreme Court declined Monday to hear Pliva Inc.'s challenge to an Iowa Supreme Court ruling that found the high court's landmark Mensing ruling did not necessarily preempt failure-to-update labeling claims against generic-drug makers.
Pliva had sought to upend the Iowa court's finding that the Supreme Court's 2011 decision in Pliva v. Mensing — which foreclosed failure-to-warn claims against generic-drug makers — did not necessarily preempt claims about a generics maker's failure to update its warning labels.
The high court indicated in a short order that the petition was declined, without elaborating. The case stems from a suit by Theresa...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!